Redwood Wealth Management Group’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$295K Sell
18,278
-1,745
-9% -$45.7K 0.13% 135
2025
Q4
$403K Buy
+20,023
New +$292K 0.17% 108
2024
Q3
Sell
-10,743
Closed -$69.3K 286
2024
Q2
$69.3K Buy
+10,743
New +$81.8K 0.05% 250
2024
Q1
Sell
-10,954
Closed -$102K 118
2023
Q4
$102K Sell
10,954
-2,226
-17% -$20.5K 0.11% 122
2023
Q3
$128K Sell
13,180
-68
-0.5% -$1.06K 0.15% 119
2023
Q2
$285K Buy
13,248
+56
+0.4% +$1.49K 0.32% 88
2023
Q1
$371K Buy
13,192
+1,343
+11% +$40.2K 0.42% 70
2022
Q4
$267K Buy
+11,849
New +$270K 0.33% 88

Other funds holding BNR

Redwood Wealth Management Group's BNR Position: Q1 2026 in Review

Redwood Wealth Management Group reduced its Burning Rock Biotech (BNR) stake by 8.7% in Q1 2026, selling an estimated $45.7K and leaving 18,278 shares worth $295K. The position accounts for 0.13% of the portfolio, ranked #135.

Redwood Wealth Management Group first reported a position in BNR in Q4 2022 and has held it in 8 quarters since. The position peaked at $403K in Q4 2025. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.

  • Redwood Wealth Management Group held 18,278 shares of Burning Rock Biotech worth $295K as of Q1 2026.
  • Redwood Wealth Management Group sold 1,745 Burning Rock Biotech shares in Q1 2026, an estimated $45.7K.
  • Burning Rock Biotech made up 0.13% of Redwood Wealth Management Group's portfolio in Q1 2026, its #135 holding.
  • Redwood Wealth Management Group first reported a position in Burning Rock Biotech in Q4 2022 and has held it in 8 quarters since.
  • Redwood Wealth Management Group's Burning Rock Biotech position peaked at $403K in Q4 2025.
  • 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.

Based on Redwood Wealth Management Group's 13F filing for Q1 2026, filed 24 Apr 2026.